Drugs Controller General para dawai laga quality ke constantly monitor kuri asey

New Delhi, 27 September : Recent reports hisab dey 53 dawai quality tests fail huishey kuntu India laga drug regulator highlight para Drugs Controller General of India (DCGI) laga chuli thakia commitment dey luisheu, pharmaceutical safety ensure kuriboley.Senior official sources hisab dey, DCGI para manufacturing companies khilaf actively action lui asey kuntu required standards of quality (NSQ) ke napunchey. Itu proactive approach para public health ke pachawoley aro healthcare system dey trust maintain kuriboley aim kuri asey.India laga drug regulator, Central Drugs Standard Control Organisation CO) para report dey kuishey ki 50 drugs upar, kutey paracetamol, Pan D, calcium aro vitamin D3 supplements aro anti-diabetes pills milaina asey, “Standard Quality laga nahoi.”Drugs laga batches kuntu quality test fail huishey itu dey, Karnataka Antibiotics, Pharmaceuticals Ltd Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Hetero Labs Limited, Nestor Pharmaceuticals Ltd, Priya Pharmaceuticals aro Scott-Edil Pharmacia Ltd nishna pharmaceuticals milaina asey.CDSCO laga drug alert kuntu hota mahina issue kurey aro August dey standard quality laga nahua catogorise kurishey, itu dey dawai laga batches para sample milaishey thakishey, Vitamin C Softgels logot Shelcal, Vitamin B Complex, vitamin C and D3 tablets, Ciprofloxacin Tablets, high blood pressure medication Telmisartan aro Atropine Sulphate aro Amoxicillin aro Potassium Clavulanate tablets nishna antibiotics.